LOQTORZI

TORIPALIMAB-TPZI · Coherus Oncology, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LOQTORZI, covering 2023-10-27 to 2026-08-04. Get the full timeline:

Most recent: EMA Authorised: Loqtorzi (toripalimab) — Topalliance Biosciences Europe Limited